Profile | GDS4284 / 215418_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 43.0538 | 23 |
GSM687648 | Patient 402 control | 172.449 | 46 |
GSM687653 | Patient 403 control | 120.889 | 39 |
GSM687658 | Patient 404 control | 188.117 | 47 |
GSM687663 | Patient 411 control | 91.5042 | 31 |
GSM687668 | Patient 422 control | 91.6098 | 33 |
GSM687673 | Patient 424 control | 70.5873 | 27 |
GSM687678 | Patient 425 control | 254.027 | 52 |
GSM687683 | Patient 427 control | 118.796 | 36 |
GSM687688 | Patient 428 control | 145.823 | 42 |
GSM687695 | Patient 441 control | 182.724 | 37 |
GSM687699 | Patient 443 control | 244.491 | 49 |
GSM687704 | Patient 444 control | 185.995 | 47 |
GSM687707 | Patient 448 control | 39.9509 | 18 |
GSM687712 | Patient 449 control | 129.135 | 39 |
GSM687719 | Patient 450 control | 125.33 | 35 |
GSM687724 | Patient 451 control | 157.606 | 41 |
GSM687728 | Patient 452 control | 170.125 | 44 |
GSM687646 | Patient 401 treated 24h | 126.127 | 39 |
GSM687649 | Patient 402 treated 24h | 137.228 | 43 |
GSM687665 | Patient 411 treated 24h | 116.907 | 35 |
GSM687651 | Patient 402 treated 4 weeks | 232.821 | 50 |
GSM687667 | Patient 411 treated 4 weeks | 168.498 | 44 |
GSM687670 | Patient 422 treated 24h | 85.2226 | 30 |
GSM687671 | Patient 422 treated 4 weeks | 86.4691 | 32 |
GSM687654 | Patient 403 treated 24h | 182.903 | 48 |
GSM687675 | Patient 424 treated 24h | 71.3891 | 26 |
GSM687685 | Patient 427 treated 24h | 30.5642 | 17 |
GSM687656 | Patient 403 treated 4 weeks | 112.306 | 39 |
GSM687677 | Patient 424 treated 4 weeks | 130.932 | 40 |
GSM687687 | Patient 427 treated 4 weeks | 156.344 | 45 |
GSM687692 | Patient 428 treated 4h | 219.128 | 50 |
GSM687716 | Patient 449 treated 4h | 63.6486 | 26 |
GSM687722 | Patient 450 treated 4h | 143.934 | 38 |
GSM687680 | Patient 425 treated 24h | 103.393 | 35 |
GSM687690 | Patient 428 treated 24h | 69.3798 | 28 |
GSM687700 | Patient 443 treated 24h | 423.964 | 57 |
GSM687705 | Patient 444 treated 24h | 96.9251 | 35 |
GSM687714 | Patient 449 treated 24h | 45.7753 | 23 |
GSM687721 | Patient 450 treated 24h | 255.688 | 49 |
GSM687682 | Patient 425 treated 4 weeks | 111.775 | 37 |
GSM687694 | Patient 428 treated 4 weeks | 68.1948 | 29 |
GSM687702 | Patient 443 treated 4 weeks | 111.414 | 34 |
GSM687718 | Patient 449 treated 4 weeks | 56.0736 | 24 |
GSM687723 | Patient 450 treated 4 weeks | 178.898 | 45 |
GSM687661 | Patient 404 treated 4h | 149.155 | 41 |
GSM687710 | Patient 448 treated 4h | 142.482 | 41 |
GSM687726 | Patient 451 treated 4h | 273.803 | 52 |
GSM687730 | Patient 452 treated 4h | 548.611 | 58 |
GSM687660 | Patient 404 treated 24h | 36.5981 | 14 |
GSM687697 | Patient 441 treated 24h | 234.773 | 46 |
GSM687709 | Patient 448 treated 24h | 174.704 | 44 |
GSM687725 | Patient 451 treated 24h | 155.623 | 39 |
GSM687729 | Patient 452 treated 24h | 37.3129 | 14 |
GSM687727 | Patient 451 treated 4 weeks | 118.767 | 34 |
GSM687731 | Patient 452 treated 4 weeks | 128.784 | 36 |